Perth tech takes out Australian start-up competition to join international finals
The WILD Program launches within the Victorian STEM sector, with first intake of 20 women
QUE Oncology launches Phase II trials
PolyActiva commences first Phase I clinical trial with potential to improve lives of millions
Paragen Bio launches in northern Queensland with $6 million investment
Azura Ophthalmics receives Series B funding to create treatment for major cause of Dry Eye Disease
MRCF announces largest investment to date by Biotechnology Translation Fund
Brandon Capital’s MRCF announces largest investment by Biotechnology Translation Fund
Okogen receives $13 Million Series A Funding for trials to treat the leading cause of eye infections
MRCF invests in San Diego ophthalmic biotech company, clinical trials to take place in Australia
Australian biotech company launched with AU$7m investment to develop therapies for treating obesity
Allergan to Acquire Elastagen to Access Next Generation Injectable Portfolio
